(Q33416874)

English

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis (English)

1 reference

Europe PubMed Central

26 July 2017

object named as

M Lutz

2

0 references

object named as

S Mielke

1

0 references

author name string

J Schmidhuber

3

1 reference

Europe PubMed Central

26 July 2017

M Kapp

4

1 reference

Europe PubMed Central

26 July 2017

D Ditz

5

1 reference

Europe PubMed Central

26 July 2017

J Ammer

6

1 reference

Europe PubMed Central

26 July 2017

H Einsele

7

1 reference

Europe PubMed Central

26 July 2017

G U Grigoleit

8

1 reference

Europe PubMed Central

26 July 2017

E Holler

9

1 reference

Europe PubMed Central

26 July 2017

D Wolff

10

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

4 August 2014

1 reference

Europe PubMed Central

26 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

26 July 2017

49

1 reference

Europe PubMed Central

26 July 2017

11

1 reference

Europe PubMed Central

26 July 2017

1412-1418

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2014.170

0 references

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Hematopoietic-cell transplantation at 50.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Comorbidity burden in patients with chronic GVHD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Therapy of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Development of a prognostic model for grading chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Everolimus for advanced pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Treatment of chronic graft-versus-host disease: Past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Molecular actions of sirolimus: sirolimus and mTor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Antileukemic activity of rapamycin in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.170

21 January 2018

Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are we making progress in GVHD prophylaxis and treatment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TLI in refractory chronic GVHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25089598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.170

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33416874&oldid=1991104771"